Skip to main content

Persian Gulf Syndrome

5
Pipeline Programs
2
Companies
1
Clinical Trials
4
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
4
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

On Market (4)

Approved therapies currently available

Pfizer
VIBRAMYCINApproved
doxycycline
Pfizer
oral1967
5K Part D
Pfizer
DOXYCYCLINE HYCLATEApproved
doxycycline
Pfizer
injection2022
Pfizer
DOXYCYCLINEApproved
doxycycline
Pfizer
oral2021
Pfizer
DOXYCHELApproved
doxycycline
Pfizer
oral1973

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
1
DoxycyclinePhase 3Small Molecule1 trial
Active Trials
NCT00007735Completed450Est. Oct 2001

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerDoxycycline

Clinical Trials (1)

Total enrollment: 450 patients across 1 trials

Antibiotic Treatment of Gulf War Veterans' Illnesses

Start: Jan 1999Est. completion: Oct 2001450 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.